Table of Contents Chapter 1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Overview 1.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Definition 1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Status and Outlook (2014-2029) 1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Comparison by Region (2014-2029) 1.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Comparison by Type (2014-2029) 1.5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Comparison by Application (2014-2029) 1.6 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Comparison by Sales Channel (2014-2029) 1.7 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak Chapter 2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment Analysis by Player 2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Market Share by Player (2017-2019) 2.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Player (2017-2019) 2.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Average Price by Player (2017-2019) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment Analysis by Type 3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Type 3.1.1 Riluzole 3.1.2 Edaravone (Radicava) 3.1.3 Other 3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Market Share by Type (2014-2019) 3.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Type (2014-2019) 3.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Average Price by Type (2014-2019) 3.5 Leading Players of Amyotrophic Lateral Sclerosis (ALS) Treatment by Type in 2019 3.6 Conclusion of Segment by Type Chapter 4 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment Analysis by Application 4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Application 4.1.1 Drugs Store 4.1.2 Other 4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Market Share by Application (2014-2019) 4.3 Leading Consumers of Amyotrophic Lateral Sclerosis (ALS) Treatment by Application in 2019 4.4 Conclusion of Segment by Application Chapter 5 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment Analysis by Sales Channel 5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Market Share by Sales Channel (2014-2019) 5.3 Leading Distributors/Dealers of Amyotrophic Lateral Sclerosis (ALS) Treatment by Sales Channel in 2019 5.4 Conclusion of Segment by Sales Channel Chapter 6 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment Analysis by Region 6.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR by Region (2014-2029) 6.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Market Share by Region (2014-2019) 6.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Region (2014-2019) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type 6.4.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type 6.5.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type 6.6.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type 6.7.3 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type 6.8.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Amyotrophic Lateral Sclerosis (ALS) Treatment Players 7.1 Mitsubishi Tanabe Pharma 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 COVID-19 Impact on Mitsubishi Tanabe Pharma 7.2 Sanofi 7.3 Mylan Pharma 7.4 Apotex 7.5 Glemark Generics 7.6 Covis Pharma 7.7 Sun Pharma 7.8 Lunan Pharma Chapter 8 Upstream and Downstream Analysis of Amyotrophic Lateral Sclerosis (ALS) Treatment 8.1 Industrial Chain of Amyotrophic Lateral Sclerosis (ALS) Treatment 8.2 Upstream of Amyotrophic Lateral Sclerosis (ALS) Treatment 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Amyotrophic Lateral Sclerosis (ALS) Treatment 8.3.1 Leading Distributors/Dealers of Amyotrophic Lateral Sclerosis (ALS) Treatment 8.3.2 Leading Consumers of Amyotrophic Lateral Sclerosis (ALS) Treatment Chapter 9 Development Trend of Amyotrophic Lateral Sclerosis (ALS) Treatment (2020-2029) 9.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (Sales and Revenue) Forecast (2020-2029) 9.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR Forecast by Region (2020-2029) 9.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR Forecast by Type (2020-2029) 9.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR Forecast by Application (2020-2029) 9.5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR Forecast by Sales Channel (2020-2029) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Example Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) Status and Outlook (2014-2029) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) Comparison by Region (2014-2029) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Comparison by Type (2014-2029) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Comparison by Application (2014-2029) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Comparison by Sales Channel (2014-2029) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Player (2017-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Player (2017-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Player in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) by Player (2017-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Player (2017-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Player in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Average Price by Player (2017-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Average Price by Player in 2019 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Players Competition Situation – Top 5 Players’ Revenue Market Share in 2017 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Players Competition Trends – Top 5 Players’ Revenue Market Share in 2019 Figure Example of Riluzole Figure Global Riluzole Sales and Growth Rate (2014-2019) Figure Example of Edaravone (Radicava) Figure Global Edaravone (Radicava) Sales and Growth Rate (2014-2019) Figure Example of Other Figure Global Other Sales and Growth Rate (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Type (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type (2014-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) by Type (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2014-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Average Price by Type (2014-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Average Price by Type in 2019 Table Leading Players of Amyotrophic Lateral Sclerosis (ALS) Treatment by Type in 2019 Figure Example of Drugs Store Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment for Drugs Store Sales and Growth Rate (2014-2019) Figure Example of Other Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment for Other Sales and Growth Rate (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Application (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application (2014-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application in 2019 Table Leading Consumers of Amyotrophic Lateral Sclerosis (ALS) Treatment by Application in 2019 Figure Example of Direct Channel Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment for Direct Channel Sales and Growth Rate (2014-2019) Figure Example of Distribution Channel Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment for Distribution Channel Sales and Growth Rate (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Sales Channel (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Sales Channel (2014-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Sales Channel in 2019 Table Leading Distributors/Dealers of Amyotrophic Lateral Sclerosis (ALS) Treatment by Sales Channel in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR by Region (2014-2029) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Region (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Region (2014-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Region in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) by Region (2014-2019) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Region (2014-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Region in 2019 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Country (2014-2019) Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Country (2014-2019) Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Country (2014-2019) Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Country (2014-2019) Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type in 2019 Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application in 2019 Figure United States Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure United States Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Country (2014-2019) Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Country (2014-2019) Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Country (2014-2019) Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Country (2014-2019) Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type in 2019 Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application in 2019 Figure Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure UK Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure UK Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure France Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure France Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Table Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Country (2014-2019) Figure Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Country (2014-2019) Table Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Country (2014-2019) Figure Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Country (2014-2019) Figure Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type in 2019 Figure Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application in 2019 Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Country (2014-2019) Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Country (2014-2019) Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Country (2014-2019) Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Country (2014-2019) Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type in 2019 Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application in 2019 Figure Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Argentina Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Argentina Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Colombia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Colombia Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Table Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Country (2014-2019) Figure Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Country (2014-2019) Table Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Country (2014-2019) Figure Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Country (2014-2019) Figure Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type in 2019 Figure Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application in 2019 Figure UAE Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure UAE Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Figure South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate (2014-2019) Figure South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million $) and Growth Rate (2014-2019) Table Company Snapshot of Mitsubishi Tanabe Pharma Table Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction of Mitsubishi Tanabe Pharma Table Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Price, Revenue, Gross Margin and Market Share of Mitsubishi Tanabe Pharma (2017-2019) Table Industrial Chain of Amyotrophic Lateral Sclerosis (ALS) Treatment Table Manufacturing Cost Structure of Amyotrophic Lateral Sclerosis (ALS) Treatment Table General Manufacturing Process of Amyotrophic Lateral Sclerosis (ALS) Treatment Table Leading Distributors/Dealers of Amyotrophic Lateral Sclerosis (ALS) Treatment Table Leading Consumers of Amyotrophic Lateral Sclerosis (ALS) Treatment Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Growth Rate Forecast (2020-2029) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate Forecast (2020-2029) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR Forecast by Region (2020-2029) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR Forecast by Type (2020-2029) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR Forecast by Application (2020-2029) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and CAGR Forecast by Sales Channel (2020-2029)

Mitsubishi Tanabe Pharma Sanofi Mylan Pharma Apotex Glemark Generics Covis Pharma Sun Pharma Lunan Pharma